Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort
Eric Jonasch, Todd M. Bauer, Kyriakos P. Papadopoulos, Elizabeth R. Plimack, Jaime R. Merchan, David F. McDermott, M. Dror Michaelson, Leonard J. Appleman, Ananya Roy, Rodolfo F. Perini, Yanfang Liu, Toni K. Choueiri
Topics & Concepts
Renal cell carcinomaMedicineCohortClear cell renal cell carcinomaOncologyClear cellPhase (matter)Internal medicineChemistryOrganic chemistryCancer, Hypoxia, and MetabolismRenal cell carcinoma treatmentAdrenal and Paraganglionic Tumors